PureTech Health
PureTech Health is a biotech company listed on the London Stock Exchange and included in the FTSE 250 Index. It was founded in 2005 by Daphne Zohar. PureTech Health develops medicines to treat serious diseases and has subsidiary companies focused on various therapeutic areas, including neuropsychiatric disorders, weight management, cognitive disorders, autoimmune diseases, and inflammatory diseases. They also have their own pipeline of therapeutics in immunology, lymphatics, and oncology.